Home › Funds › JW Asset Management, LLC › LGND
JW Asset Management, LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
JW Asset Management, LLC reported holding 15,000 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 1.95% of its reported portfolio and ranking #6 among its reported holdings. JW Asset Management, LLC has disclosed LGND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JW Asset Management, LLC's LGND position evolved
JW Asset Management, LLC first disclosed a stake in LGND in Q2 2026 at 4,000 shares (US$1.3M). The position peaked in Q3 2026 at 15,000 shares, worth US$4.7M. Across 2 filings, JW Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 15,000 shares valued at US$4.7M — an increase of 11,000 shares quarter over quarter.. Notable position changes include a 275% increase in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 4.00K | $1.26M | New |
| Q3 2026 | 15.00K | $4.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 98.75K sh · $30.88M · Q3 2026
More on JW Asset Management, LLC
FAQ
How long has JW Asset Management, LLC held LGND?
JW Asset Management, LLC has disclosed LGND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is JW Asset Management, LLC's current position in LGND?
As of Q3 2026, JW Asset Management, LLC holds 15.00K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $4.69M, representing 1.95% of its reported portfolio and ranking #6.
Has JW Asset Management, LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), JW Asset Management, LLC increased its position in LGND. The position peaked in Q3 2026 at 15.00K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.